Comparative Study
Journal Article
Observational Study
Add like
Add dislike
Add to saved papers

30-day mortality after haemodialysis vascular access surgery: a retrospective observational study.

PURPOSE: The prevalence of haemodialysis is increasing globally. There is a consensus of international opinion that permanent vascular access is preferred for haemodialysis. Patients with end-stage renal disease carry a high burden of cardiovascular comorbidity. There is a lack of data to quantify the post-operative risk of vascular access surgery. This study looked to establish the 30-day post-operative mortality for patients undergoing surgery to create vascular access and to measure for differences between the types of access created and the mode of anaesthesia.

METHODS: We conducted a retrospective study of all cases over a 5-year period at a tertiary renal unit in the UK. Data recorded included co-morbidity, time on renal replacement therapy, type of access created, mode of anaesthesia and 30-day mortality. The incident risk was calculated and logistic regression used to calculate the adjusted odds ratio.

RESULTS: A total of 1404 operations were included. 30-day mortality for the whole cohort was 1.1% (16/1404). The adjusted odds ratio of death at 30 days using an upper limb fistula as a reference was 5.27 for an upper limb graft (p = 0.005) and 11.51 (p = 0.007) for any lower limb access. Using local anaesthesia as a reference the adjusted odds ratio for surgery under general anaesthesia was 6.28 (p = 0.001).

CONCLUSIONS: Vascular surgery for haemodialysis is associated with significant and variable post-operative mortality; this study highlights the need for careful pre-operative planning in this complex group of patients.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app